Effects of octreotide on lower esophageal sphincter in patients with cirrhosis and portal hypertension

Digestive Diseases and Sciences

Volumn 43, Issue 7, 1998, Pages 1566-1571

  Barrioz, Thierry ^a   Borderie, Catherine ^a   Strock, Paul ^a   Ingrand, Pierre ^a   Fort, Eric ^a   Silvain, Christine ^a   Beauchant, Michel ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Cirrhosis; Lower esophageal sphincter; Octreotide

Indexed keywords

OCTREOTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESOPHAGUS MANOMETRY; ESOPHAGUS PRESSURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LOWER ESOPHAGUS SPHINCTER; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOGASTRIC JUNCTION; ESOPHAGUS; FEMALE; HORMONES; HUMANS; HYPERTENSION, PORTAL; INFUSIONS, INTRAVENOUS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MANOMETRY; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OCTREOTIDE; TIME FACTORS;

EID: 0031852688     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018879218508     Document Type: Article

References (35)

1. Besson I, Ingrand P, Person B, Boutroux D, Hereshach D, Bernard P, Hochain P, Larricq J, Gourlaouen A, Rihard D, Mostefa Kara N, Legoux JL, Pillegand B, Becker MC, Di Costanzo J, Metreau JM, Silvain C, Beauchant M: Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 333:555-560, 1995
2. Sieber CS, Lee F-Y, Groszmann RJ: Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats. Hepatology 23:1218-1223, 1996
3. Cerini R, Lee SS, Hadengue A, Koshy A, Girod C, Lebrec D: Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension. Gastroenterology 94:703-708, 1988
4. Cerini R, Braillon A, Hadengue A, Koshy A, Lee SS, Lebrec D: Somatostatin analogue improves survival in conscious cirrhotic rats subjected to gastrointestinal bleeding. Clin Sci 77:7-4, 1989
5. Yates J, Nott DM, Kynaston H, Davies N, Jin Lai L, Billington D, Shields R, Jenkins SA: Hypovolaemia and reperfusion in portal hypertension: Effects of somatostatin, octreotide and vasopressin. Gut 34(suppl 3):S6, 1943
6. MacCormick PA, Dick R, Siringo S, Wagstaff D, Chesta J, MacIntyre N, Burroughs AK: Octreotide reduces azygos blood flow in cirrholic patients with portal hypertension. Eur J Gastroenterol Hepatol 2:489-492, 1990
7. Navasa M, Bosch J, Chesta J, Bru C, Pizcuela P, Garcia-Pagan JC, Betz C, Casamitjana R, Rodes J: Haemodynamic effects of subcutaneous administration of SMS 201-995, a long acting somatostatin analog in patients with cirrhosis and portal hypertension. J Hepatol 7(suppl 1):S64, 1988
8. Bosch J, Groszmann RJ: Measurement of the azygos venous blood flow through gastroesophageal collaterals in cirrhosis. Hepatology 4:424-429, 1984
9. Eriksson LS, Brundin T, Soderlund C, Wharen J: Haemodynamics effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 22:919-925, 1987
10. Hanisch E, Doertenbach J, Usadel KH: Somatostatin in acute bleeding oesophageal varices. Pharmacology and rational for use. Drugs 44(suppl 2):24-35, 1992
11. Jenkins SA, Baxter JN, Ellenbogen S, Snowdon S, Whitehouse G, Shields R: Effects of somatostatin and SMS 201-995 on hepatic and systemic haemodynamics in patients with cirrhosis and portal hypertension. Gut 29:A720, 1988
12. Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, Lo KJ: Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 110:229-234, 1992
13. Mastai R, Grande L, Bosch J, Bruix J, Rigau J, Kravetz D, Navasa M, Pera C, Rodes J: Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension. Hepatology 6:1244-1247, 1986
14. Hosking SW, Doss W, El-Zeing H, Robinson P, Barsoum MS, Johnson AG: Pharmacological constriction of lower esophageal sphincter. A simple method of arresting variceal haemorrhage. Gut 29:1098-1102, 1988
15. Kleber G, Sauerbruch T, Fischer G, Geigenberger G, Paumgartner G: Reduction of transmural oesophageal variceal pressure by metoclopramide. J Hepatol 12:362-366, 1991
16. Stanciu C, Cijevschi C, Stan M, Sandulescu E: Endoscopic intravascular esophageal pressure measurements in cirrhotic patients: Response to metoclopramide. Hepato-Gastroenterol 40:173-175, 1993
17. Taranto D, Suozzo R, de Sio I, Romano M, Caporaso N, Del Vecchio Blanco C, Coltorti M: Effect of metoclopramide on transmural oesophageal variceal pressure and portal blood flow in cirrhotic patients. Digestion 47:56-60, 1990
18. Ohta M, Hashizume M, Tanoue K, Ueno K, Komori K, Ishii T, Kitano S, Sugimachi K: Metoclopramide inhibits development of esophageal varices in rat model. Dig Dis Sci 39:1853-1858, 1994
19. Constantinescu R: Metoclopramide as adjuvant to emergency sclerotherapy of bleeding varices. Endoscopy 27:S98, 1995
20. Gupta IP, Sharma MP: Control of variceal bleed with metoclopramide. Indian J Gastroenterol 10:10-11, 1991
21. Feu F, Mas A, Bosch J, Salmeron JM, Garcia Pagan JC, Teres J, Rodes J: Domperidone or metoclopramide vs placebo in the prevention of early variceal rebleeding in cirrhosis. A prospective, randomized trial. J Hepatol 7:S31, 1988
22. Heil T, Mattes P, Raptis S: Effects of somatostatin and human gastrin I on the lower esophageal sphincter in man. Digestion 15:461-468, 1977
23. Gunshefski LA, Rifley WJ, Slattery DW, Schifini JJ, Hartsuck M, Little AG: Somatostatin stimulation of the normal esophagus. Am J Surg 163:59-62, 1992
24. Silvain C, Carpentier S, Sautereau D, Czernikow B, Métreau JM, Fort E, Ingrand P, Boyer J, Pillegand B, Doffoel M, Dhumeaux D, Beauchant M: Terlipressin plus transdermal nitroglycerin versus octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial. Hepatology 18:61-65, 1993
25. Holloway RH, Penagini R, Ireland AC: Criteria for objective definition of transient lower esophageal sphincter relaxation. Am J Physiol 31:G128-G133, 1995
26. Dent J, Holloway RH, Toouli J, Dodds WJ: Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastro-oesophageal reflux. Gut 29:1020-1028, 1998
27. Schoeman MN, Tippett MD, Akkermans LMA, Dent J, Holloway RH: Mechanisms of gastro-oesophageal reflux in ambulant healthy subjects. Gastroenterology 108:83-91, 1995
28. Mittal RK, Holloway R, Dent J: Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects. Gastroenterology 109:1547-1554, 1995
29. Wyman JB, Dent J, Heddle R, Dodds WJ, Tooli J, Downton J: Control of belching by the lower oesophageal sphincter. Gut 31:639-646, 1990
30. Boulant J, Mathieu S, D'Amato M, Abergel A, Dapoigny M, Bommelaer G: Cholecystokinine in transient lower sphincter relaxation due to gastric distension in humans. Gut 40:575-581, 1997
31. Singaram C, Sengupta A, Sugarbaker DJ, Goyal RK: Peptidergic innervation of the human esophageal smooth muscle. Gastroenterology 101:1256-1263, 1991
32. D'Arienzo A, Ambrogio G, Di Siervi P, Perna E, Squame G, Mazzaca G: A randomized comparison of metoclopramide and domperidone on plasma aldosterone concentration and on spironolactone-induced diuresis in ascitic cirrhotic patients. Hepatology 5:854-857, 1985
33. McCormick PA, Greenslade L, Chin J, Dick R, McIntyre N, Burroughs AK: The effect of the combination of octreotide and metoclopramide on azygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 5:839-843, 1993
34. Reichlin S: Somatostatin. N Engl J Med 309:1495-1501, 1983
35. Pugh RMH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-659, 1973